Dr. Kataki is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2050 Kenny Rd
Fl 3
Columbus, OH 43221Phone+1 614-293-4969Fax+1 614-293-6111
Education & Training
- Baylor College of MedicineResidency, Neurology, 2000 - 2003
- University of Texas Health Science Center at HoustonResidency, Internal Medicine, 1999 - 2000
- Baylor College of MedicineInternship, Transitional Year, 1998 - 1999
- University of AthensClass of 1989
Certifications & Licensure
- OH State Medical License 2003 - 2026
- NY State Medical License 2023 - 2025
- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Publications & Presentations
PubMed
- Correction to: Self-Administered Gerocognitive Examination: longitudinal cohort testing for the early detection of dementia conversion.Douglas W Scharre, Shu Ing Chang, Haikady N Nagaraja, Natalie C Wheeler, Maria Kataki
Alzheimer's Research & Therapy. 2022-02-05 - 15 citationsSelf-Administered Gerocognitive Examination: longitudinal cohort testing for the early detection of dementia conversion.Douglas W Scharre, Shu Ing Chang, Haikady N Nagaraja, Natalie C Wheeler, Maria Kataki
Alzheimer's Research & Therapy. 2021-12-06 - 94 citationsType 2 diabetes mellitus, brain atrophy, and cognitive declineChris Moran, Richard Beare, Wei Wang, Michele L. Callisaya, Velandai Srikanth
Neurology. 2019-02-19
Press Mentions
- Albany Medical Center Becomes the First in Northeastern New York to Offer Alzheimer's DrugAugust 28th, 2024
- Associations of Regional Brain Structural Differences with Aging, Modifiable Risk Factors for Dementia, and Cognitive PerformanceDecember 2nd, 2019
- Association of Altered Liver Enzymes with AD, Cognition, Neuroimaging Measures, and Cerebrospinal Fluid BiomarkersJuly 31st, 2019
- Join now to see all
Professional Memberships
- Member
Other Languages
- French, Greek
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: